Gaurisankar Sa

Employment

• Bose Institute Senior Professor
  1995 - Present

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (8)

• Revisiting tumor immunogenicity through the lens of mutant p53: Implications for cancer immunotherapy
  Apoptosis 2026 0 citations DOI: 10.1007/s10495-026-02409-9
  +Save
• Tumor Microenvironment: The Kingpin in the Emergence of Resistance to Cancer Therapy
  Cancer Control 2026 0 citations DOI: 10.1177/10732748261465852
  +Save
• The Role of Nuclear Factor-κB in Cancer Immunity and Immunoediting
  Cancer Control 2025 9 citations DOI: 10.1177/10732748251406677
  +Save
• Down-regulation and reduced surface-presentation of neoantigens in cancer stem cells decide the fate of cancer immunotherapy: An in-silico mechanistic hypothesis
  In Silico Research in Biomedicine 2025 1 citation DOI: 10.1016/j.insi.2025.100071
  +Save
• Immune evasion by cancer stem cells ensures tumor initiation and failure of immunotherapy
  Exploration of Immunology 2023 9 citations DOI: 10.37349/ei.2023.00108
  +Save
• GFI1/HDAC1‐axis differentially regulates immunosuppressive CD73 in human tumor‐associated FOXP3+Th17 and inflammation‐linked Th17 cells
  European Journal of Immunology 2021 16 citations DOI: 10.1002/eji.202048892
  +Save
• Tumor-infiltrating T-regulatory cells adapt to altered metabolism to promote tumor-immune escape
  Current Research in Immunology 2021 101 citations DOI: 10.1016/j.crimmu.2021.08.002
  +Save
• Regulatory lymphocytes: the dice that resolve the tumor endgame
  Applied Cancer Research 2020 12 citations DOI: 10.1186/s41241-020-00091-0
  +Save